Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial.
暂无分享,去创建一个
Joshua M Hare | Phillip Ruiz | Peter A. Altman | Eduard Ghersin | Richard George | C. Wong Po Foo | A. Lardo | A. Heldman | J. Brinker | D. Rouy | E. Ghersin | J. Hare | P. Ruiz | G. Gerstenblith | R. George | Elayne Breton | Alan W Heldman | Ian K McNiece | Jeffrey A Brinker | Albert Lardo | J. Fishman | Cheryl Wong Po Foo | Didier Rouy | Gary Gerstenblith | Peter V Johnston | M. Lowery | Melissa J. Tracy | Elayne Breton | Joel E Fishman | Darcy L DiFede Velazquez | Juan P Zambrano | Viky Y Suncion | Melissa Tracy | Janice Davis-Sproul | Ivonne H Schulman | John Byrnes | Adam M Mendizabal | Maureen H Lowery | Peter Altman | Alexandra Amador | Jose Da Silva | P. Altman | I. Mcniece | J. Byrnes | J. Zambrano | V. Suncion | I. Schulman | Adam M. Mendizabal | A. Amador | Jose da Silva | J. Davis-Sproul | A. Mendizabal | Peter V. Johnston | Melissa Tracy
[1] J. Lupón,et al. Quality of life monitoring in ambulatory heart failure patients: temporal changes and prognostic value , 2013, European journal of heart failure.
[2] K. Hatzistergos,et al. Cell-based therapy for prevention and reversal of myocardial remodeling. , 2012, American journal of physiology. Heart and circulatory physiology.
[3] V. Jeevanantham,et al. Adult Bone Marrow Cell Therapy Improves Survival and Induces Long-Term Improvement in Cardiac Parameters: A Systematic Review and Meta-Analysis , 2012, Circulation.
[4] Dejian Lai,et al. Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial. , 2012, JAMA.
[5] Daniel Berman,et al. Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial , 2012, The Lancet.
[6] Marcus F Stoddard,et al. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial , 2011, The Lancet.
[7] Mark A Sussman,et al. Abstract 13079: Synergistic Effect of Human Cardiac Stem Cells and Bone Marrow Mesenchymal Stem Cells to Reduce Infarct Size and Restore Cardiac Function , 2011 .
[8] J. Hare,et al. Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease. , 2011, Circulation research.
[9] S. Morbelli,et al. Mesenchymal stem cells impair in vivo T-cell priming by dendritic cells , 2011, Proceedings of the National Academy of Sciences.
[10] P. Pattany,et al. Safety of serial MRI in patients with implantable cardioverter defibrillators , 2011, Heart.
[11] T. Henry,et al. Intramyocardial, Autologous CD34+ Cell Therapy for Refractory Angina , 2011, Circulation research.
[12] A. Zeiher,et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI): final 5-year results suggest long-term safety and efficacy , 2011, Clinical Research in Cardiology.
[13] Peter A. Altman,et al. Intramyocardial Stem Cell Injection in Patients With Ischemic Cardiomyopathy: Functional Recovery and Reverse Remodeling , 2011, Circulation research.
[14] Peter A. Altman,et al. Rationale and design of the Transendocardial Injection of Autologous Human Cells (bone marrow or mesenchymal) in Chronic Ischemic Left Ventricular Dysfunction and Heart Failure Secondary to Myocardial Infarction (TAC-HFT) trial: A randomized, double-blind, placebo-controlled study of safety and effi , 2011, American heart journal.
[15] E. Marbán,et al. Intramyocardial injection of autologous cardiospheres or cardiosphere-derived cells preserves function and minimizes adverse ventricular remodeling in pigs with heart failure post-myocardial infarction. , 2011, Journal of the American College of Cardiology.
[16] R. Bray,et al. Clinical cytometry and progress in HLA antibody detection. , 2011, Methods in cell biology.
[17] S. Dymarkowski,et al. Time course of infarct healing and left ventricular remodelling in patients with reperfused ST segment elevation myocardial infarction using comprehensive magnetic resonance imaging , 2011, European Radiology.
[18] R. Weisel,et al. Differentiation of Allogeneic Mesenchymal Stem Cells Induces Immunogenicity and Limits Their Long-Term Benefits for Myocardial Repair , 2010, Circulation.
[19] P. Pattany,et al. Bone Marrow Mesenchymal Stem Cells Stimulate Cardiac Stem Cell Proliferation and Differentiation , 2010, Circulation research.
[20] Hong Wang,et al. Extended Report , 2022 .
[21] S. Fazel,et al. Aging impairs the angiogenic response to ischemic injury and the activity of implanted cells: combined consequences for cell therapy in older recipients. , 2010, The Journal of thoracic and cardiovascular surgery.
[22] R. Weisel,et al. What's New in Cardiac Cell Therapy? Allogeneic Bone Marrow Stromal Cells as “Universal Donor Cells” , 2010, Journal of cardiac surgery.
[23] Joshua M Hare,et al. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. , 2009, Journal of the American College of Cardiology.
[24] P. Pattany,et al. Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity , 2009, Proceedings of the National Academy of Sciences.
[25] Albert C. Lardo,et al. Recent developments in wide-detector cardiac computed tomography , 2009, The International Journal of Cardiovascular Imaging.
[26] J. Gorman,et al. Allogeneic mesenchymal precursor cell therapy to limit remodeling after myocardial infarction: the effect of cell dosage. , 2009, The Annals of thoracic surgery.
[27] G. Dini,et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study , 2008, The Lancet.
[28] L. Amado,et al. Early improvement in cardiac tissue perfusion due to mesenchymal stem cells. , 2008, American journal of physiology. Heart and circulatory physiology.
[29] Peter A. Altman,et al. Transendocardial autologous bone marrow in chronic myocardial infarction using a helical needle catheter: 1-year follow-up in an open-label, nonrandomized, single-center pilot study (the TABMMI study). , 2007, American heart journal.
[30] Jonathan Lessick,et al. Is functional improvement after myocardial infarction predicted with myocardial enhancement patterns at multidetector CT? , 2007, Radiology.
[31] Joshua M Hare,et al. Multimodality noninvasive imaging demonstrates in vivo cardiac regeneration after mesenchymal stem cell therapy. , 2006, Journal of the American College of Cardiology.
[32] A. Zeiher,et al. Transcoronary transplantation of progenitor cells after myocardial infarction. , 2006, The New England journal of medicine.
[33] A. Zeiher,et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. , 2006, The New England journal of medicine.
[34] M. Yacoub,et al. Human mesenchymal stem cells induce T cell anergy and downregulate T cell allo-responses via the TH2 pathway: relevance to tissue engineering human heart valves. , 2006, Tissue engineering.
[35] Joshua M Hare,et al. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[36] D. Katritsis,et al. CORONARY ARTERY DISEASE Original Studies Transcoronary Transplantation of Autologous Mesenchymal Stem Cells and Endothelial Progenitors Into Infarcted Human Myocardium , 2005 .
[37] Elmar Spuentrup,et al. Assessment of myocardial viability in reperfused acute myocardial infarction using 16-slice computed tomography in comparison to magnetic resonance imaging. , 2005, Journal of the American College of Cardiology.
[38] G. Sukhikh,et al. Mesenchymal Stem Cells , 2002, Bulletin of Experimental Biology and Medicine.
[39] O. Ringdén,et al. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. , 2003, Experimental hematology.
[40] M. Ashraf,et al. Implantation of bone marrow stem cells reduces the infarction and fibrosis in ischemic mouse heart. , 2003, Journal of molecular and cellular cardiology.
[41] L. Muul,et al. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[42] M. Cerqueira,et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association , 2002, The international journal of cardiovascular imaging.
[43] W. V. D. van den Heuvel,et al. Psychometric properties of the Minnesota Living with Heart Failure Questionnaire (MLHF-Q) , 2001, Clinical rehabilitation.
[44] S. Goldstein,et al. Left ventricular shape is the primary determinant of functional mitral regurgitation in heart failure. , 1992, Journal of the American College of Cardiology.
[45] J. Cohn,et al. Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Pimobendan Multicenter Research Group. , 1992, American heart journal.
[46] G. Lamas,et al. Effects of left ventricular shape and captopril therapy on exercise capacity after anterior wall acute myocardial infarction. , 1989, The American journal of cardiology.